Kristen M. Hege's most recent trade in Mersana Therapeutics Inc was a trade of 61,500 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 12, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Mersana Therapeutics Inc | Kristen M. Hege | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 61,500 | 61,500 | - | - | Stock Option (right to buy) | |
Adaptimmune Therapeutics P... | Kristen M. Hege | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 660,000 | 660,000 | - | - | Option to purchase Ordinary Shares | |
Mersana Therapeutics Inc | Kristen M. Hege | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 55,000 | 55,000 | - | - | Stock Option (right to buy) | |
Adaptimmune Therapeutics P... | Kristen M. Hege | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2024 | 81,906 | 81,906 | - | - | Option to purchase Ordinary Shares | |
Mersana Therapeutics Inc | Kristen M. Hege | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 6,447 | 6,447 | - | - | Stock Option (right to buy) | |
Graphite Bio Inc | Kristen M. Hege | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jul 2023 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
Mersana Therapeutics Inc | Kristen M. Hege | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2023 | 3,654 | 3,654 | - | - | Stock Option (right to buy) | |
Mersana Therapeutics Inc | Kristen M. Hege | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 18,355 | 18,355 | - | - | Stock Option (right to buy) | |
Mersana Therapeutics Inc | Kristen M. Hege | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 14,467 | 14,467 (0%) | 0% | 0 | Common Stock | |
Mersana Therapeutics Inc | Kristen M. Hege | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2023 | 3,451 | 3,451 | - | - | Stock Option (right to buy) | |
Graphite Bio Inc | Kristen M. Hege | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2022 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
Mersana Therapeutics Inc | Kristen M. Hege | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 45,000 | 45,000 | - | - | Stock Option (right to buy) | |
Mersana Therapeutics Inc | Kristen M. Hege | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 10,416 | 10,416 | - | - | Stock Option (right to buy) | |
Mersana Therapeutics Inc | Kristen M. Hege | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2021 | 25,050 | 25,050 | - | - | Stock Option (right to buy) | |
Mersana Therapeutics Inc | Kristen M. Hege | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 2,547 | 2,547 | - | - | Stock Option (right to buy) |